Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Combined anti‐PD‐1 and anti‐CTLA‐4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action - Willsmore - 2021 - European Journal of Immunology - Wiley Online Library
Immune checkpoint inhibitors of PD-L1 as cancer therapeutics | Journal of Hematology & Oncology | Full Text
PD1 Antibody Selection Tool | Bio X Cell
Ipilimumab alone or ipilimumab plus anti-PD-1 therapy in patients with metastatic melanoma resistant to anti-PD-(L)1 monotherapy: a multicentre, retrospective, cohort study - The Lancet Oncology
PD-1
Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma | NEJM
Frontiers | Adverse Effects of Anti-PD-1/PD-L1 Therapy in Non-small Cell Lung Cancer
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors
Learning from PD-1 Resistance: New Combination Strategies: Trends in Molecular Medicine
A Brief Introduction to PD-1 Antibodies and Immunotherapy | ProSci Incorporated
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake
JCM | Free Full-Text | Anti-PD-1 and Novel Combinations in the Treatment of Melanoma—An Update
Frontiers | Research Progress of Anti-PD-1/PD-L1 Immunotherapy Related Mechanisms and Predictive Biomarkers in NSCLC
Anti–PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases | Science Immunology
PD-1
Schematic representation of PD-1 and anti-PD-1/PD-L1 mechanisms of... | Download Scientific Diagram
The role of anti-PD-1 and anti-PD-L1 agents in the treatment of diffuse large B-cell lymphoma: The future is now - ScienceDirect
Efficacy of anti-PD-1 therapy. HCC was induced by HDI of MET/β-catenin.... | Download Scientific Diagram
Anti–PD-1 Therapy in Melanoma - ScienceDirect
IJMS | Free Full-Text | PD-L1 in Systemic Immunity: Unraveling Its Contribution to PD-1/PD-L1 Blockade Immunotherapy
Current issues and perspectives in PD-1 blockade cancer immunotherapy | International Journal of Clinical Oncology
Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy: Molecular Therapy
Biomolecules | Free Full-Text | The Emerging Role of IL-9 in the Anticancer Effects of Anti-PD-1 Therapy
News
